CDH1 and ovarian cancer: We found all three ascites from ovarian cancer patients reduced the expression of an epithelial marker (E-cadherin), and increased the expression of mesenchymal markers (Snail and Vimentin) (Figure 1D and 1E) and these changes were statistically significant (Supplementary Figure S1A and S1B).